Compass Ion Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.4M Sell
12,346
-244
-2% -$24.2K 0.12% 94
2026
Q1
$1.18M Sell
12,590
-1,101
-8% -$110K 0.11% 96
2025
Q4
$1.35M Buy
13,691
+8
+0.1% +$774 0.13% 82
2025
Q3
$1.16M Buy
13,683
+34
+0.2% +$2.69K 0.11% 99
2025
Q2
$929K Sell
13,649
-296
-2% -$18.8K 0.1% 106
2025
Q1
$844K Buy
13,945
+51
+0.4% +$3.56K 0.1% 119
2024
Q4
$960K Buy
13,894
+10,363
+293% +$738K 0.11% 103
2024
Q3
$233K Sell
3,531
-36
-1% -$2.3K 0.03% 233
2024
Q2
$203K Hold
3,567
0.03% 221
2024
Q1
$203K Sell
3,567
-52
-1% -$3.12K 0.03% 220
2023
Q4
$227K Sell
3,619
-1,684
-32% -$95.2K 0.04% 212
2023
Q3
$306K Buy
+5,303
New +$334K 0.05% 177

Other funds holding INCY

Compass Ion Advisors's INCY Position: Q2 2026 in Review

Compass Ion Advisors reduced its Incyte (INCY) stake by 1.9% in Q2 2026, selling an estimated $24.2K and leaving 12,346 shares worth $1.4M. The position accounts for 0.12% of the portfolio, ranked #94.

Compass Ion Advisors first reported a position in INCY in Q3 2023 and has held it in 12 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Compass Ion Advisors held 12,346 shares of Incyte worth $1.4M as of Q2 2026.
  • Compass Ion Advisors sold 244 Incyte shares in Q2 2026, an estimated $24.2K.
  • Incyte made up 0.12% of Compass Ion Advisors's portfolio in Q2 2026, its #94 holding.
  • Compass Ion Advisors first reported a position in Incyte in Q3 2023 and has held it in 12 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Compass Ion Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.